2 studies found for:    19095497 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced Hcc
Condition: Advanced Hepatocellular Carcinoma
Intervention: Drug: Immuncell-LC
2 Completed
Has Results
A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006);   Drug: Placebo

Indicates status has not been verified in more than two years